Sign in
4

Changes in Ownership

Bone Biologics Corp Filed Acc 0001493152-16-008575

Options or other derivatives

  • Chief Technology Officer acquired 54,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Treat William Jay · Chief Technology Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-03-14 Grant or award : show line 1 in the form Stock Option (right to buy) +54,000 54,000 D
Loading xslF345X03/form4.xml…